156100 — L&K Biomed Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Market Cap
KR₩135bn
Enterprise Value
KR₩135bn
Revenue
KR₩36bn

Annual balance sheet for L&K Biomed Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4,910	16,108	7,395	9,668	16,835
Net Total Accounts Receivable
Net Total Receivables	3,319	2,173	6,125	11,724	16,413
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	32,044	37,964	36,147	44,417	63,566
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7,890	9,271	8,514	9,012	10,005
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	58,995	59,285	52,663	62,762	83,061
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	19,664	12,613	37,981	22,763	39,074
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	27,381	34,818	40,395	27,411	40,565
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Other Equity
Total Equity	31,615	24,467	12,268	35,351	42,496
Total Liabilities & Shareholders' Equity	58,995	59,285	52,663	62,762	83,061
Total Common Shares Outstanding
Total Preferred Shares Outstanding